Cristóbal Belda-Iniesta
0000-0003-3254-7492
Publication & Citation Trends
Publications
216 total
No changes in hemostasis after COVID-19–heterologous vaccination schedule: A subanalysis of the phase 2 CombiVacS study OA
Cited by 0
Semantic Scholar
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study OA
Cited by 61
Semantic Scholar
Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS Study
Cited by 0
Semantic Scholar
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study OA
Cited by 8
Semantic Scholar
Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study
Cited by 0
Semantic Scholar
A New Natural Antimycotic Agent is Effective Against Oropharyngeal Candidiasis: The VIPROCAN Study OA
Cited by 1
Semantic Scholar
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR OA
Cited by 38
Semantic Scholar
Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)
Cited by 22
Semantic Scholar
Optimising SARS-CoV-2 vaccination schedules OA
Cited by 2
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(33)
Lung Cancer Treatments and Mutations
(31)
Chromatin Remodeling and Cancer
(27)
Fibroblast Growth Factor Research
(26)
Sarcoma Diagnosis and Treatment
(22)
Affiliations
Madrid Institute for Advanced Studies
University of Vermont
Universidad San Pablo CEU
NewYork–Presbyterian Hospital
The University of Texas MD Anderson Cancer Center